MGC Pharmaceuticals Ltd

Receive alerts
Market Cap:
$53.3 m
52 weeks high
52 weeks low

Filter by article type

Viewing results 1-25 of 43


MGC Pharmaceuticals secures $4.75 million; on track to LSE listing this year

The company is actively progressing towards a listing on the London Stock Exchange in the second half of calendar year 2019. ...

on 21/8/19

MGC Pharmaceuticals signs partnership to launch international medicinal cannabis research hub

CannaHub is a new addition to the MGC projects currently underway with the Royal Melbourne Institute of Technology, and will be formally launched in Q1 2019....

on 19/11/18

MGC Pharmaceuticals granted trading halt pending MGC Derma sale news

The halt will remain until the start of trading on November 5 or when an announcement is released....

on 1/11/18

MGC Pharmaceuticals rockets up 37% after reimbursement win for cannabis epilepsy therapeutic

The company has started manufacturing the product and plans to launch it later this year....

on 11/10/18

MGC Pharmaceuticals attracts $5 million for medical cannabis facility in Malta

Cannabis produced at the facility to be used in the production of GMP-grade pharmaceutical products....

on 12/4/18

MGC Pharmaceuticals commencing production of CannEpil for epilepsy

Pre-registered patients for the drug is set to generate over $1 million in sales....

on 29/3/18

MGC Pharmaceuticals launches cannabidiol cream for psoriasis

The global market for psoriasis treatment was valued at US$7.8 billion in 2015....

on 4/1/18
Retail & consumer

MGC Pharmaceuticals and Petrel Energy are the ASX Most Active, but head in different directions

There is a lot of activity in the small caps for the first session of the week....

on 23/10/17
Retail & consumer

MGC Pharmaceuticals tops the ASX Most Traded on back of medical cannabis revenues

The company has traded over $5 million worth of stock in the first 45 minutes....

on 20/10/17

MGC Pharmaceuticals’ medicinal cannabis plants enter flowering phase

The harvesting of the plants will commence in the next 2 weeks. ...

on 13/10/17

MGC Pharmaceuticals aims to develop new medicinal cannabis strains

The new research builds on the company’s existing programs in Europe....

on 5/6/17

MGC Pharmaceuticals appoints Roby Zomer as CEO

Roby Zomer is one of the founders of MGC Pharmaceuticals....

on 11/5/17

MGC Pharmaceuticals to reveal medical cannabis agreement

The halt will remain in place until Wednesday 3rd May 2017....

on 1/5/17

MGC Pharmaceuticals bags $10M for medical cannabis growth

MGC’s cosmetics and dermatological product sales is growing....

on 17/3/17

MGC Pharmaceuticals gets ready to raise

The halt will remain in place until Friday 17th March 2017....

on 15/3/17

MGC Pharmaceuticals to reveal medicinal cannabis next steps

The halt will remain in place until Tuesday 14th February 2017....

on 10/2/17

Roto-Gro International joins ASX list of cannabis-tech companies

Roto-Gro produces an automated hydroponic growing system....

on 8/2/17

MGC Pharmaceuticals secures European approval for derma products

MGC Pharmaceuticals (ASX:MXC) has received approval in Europe for its cannabidiol based dermatological products for the relief of acne, psoriasis and seborrhoea skin conditions....

on 9/1/17

MGC Pharmaceuticals wins Czech order for cannabidiol based cosmetics

MGC Pharmaceuticals (ASX:MXC) has received the first major sales order for its cannabidiol-based cosmetics products from the Czech Republic....

on 2/12/16

MGC Pharmaceuticals registering dermatological products in Europe

MGC Pharmaceuticals Ltd (ASX:MXC) has commenced the registration of its cannabidiol based dermatological products with the European Cosmetics Products Notification Portal (CPNP)....

on 7/11/16